These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36400256)

  • 1. Solventless amorphization and pelletization using a high shear granulator. Part I; feasibility study using indomethacin.
    Kondo K; Rades T
    Eur J Pharm Biopharm; 2022 Dec; 181():147-158. PubMed ID: 36400256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solventless amorphization and pelletization using a high shear granulator. Part II; Preparation of co-amorphous mixture-layered pellets using indomethacin and arginine.
    Kondo K; Rades T
    Eur J Pharm Biopharm; 2022 Dec; 181():183-194. PubMed ID: 36400253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solventless granulation and spheronization of indomethacin crystals using a mechanical powder processor: Effects of mechanically induced amorphization on particle formation.
    Kondo K; Miyamoto K; Miura S; Niwa T
    Eur J Pharm Biopharm; 2020 Sep; 154():348-358. PubMed ID: 32755618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y; Rantanen J; Yang M; Bohr A
    Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets.
    da Costa NF; Azevedo RF; Lopes JA; Fernandes AI; Pinto JF
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
    Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel pelletization technique through an extremely high-shear process using a mechanical powder processor to produce high-dose small core granules suitable for film coating.
    Kondo K; Kato A; Niwa T
    Int J Pharm; 2015 Apr; 483(1-2):101-9. PubMed ID: 25681728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin.
    Ojarinta R; Heikkinen AT; Sievänen E; Laitinen R
    Eur J Pharm Biopharm; 2017 Mar; 112():85-95. PubMed ID: 27888143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
    Bahl D; Bogner RH
    Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability.
    Fael H; Demirel AL
    Int J Pharm; 2021 May; 600():120448. PubMed ID: 33675920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ.
    Doreth M; Hussein MA; Priemel PA; Grohganz H; Holm R; Lopez de Diego H; Rades T; Löbmann K
    Int J Pharm; 2017 Mar; 519(1-2):343-351. PubMed ID: 28115260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Glycerol as an Enabling Excipient for Microwave-Induced In Situ Drug Amorphization.
    Hempel NJ; Morsch F; Knopp MM; Berthelsen R; Löbmann K
    J Pharm Sci; 2021 Jan; 110(1):155-163. PubMed ID: 33058897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Process analytical technology (PAT) approach to the formulation of thermosensitive protein-loaded pellets: Multi-point monitoring of temperature in a high-shear pelletization.
    Kristó K; Kovács O; Kelemen A; Lajkó F; Klivényi G; Jancsik B; Pintye-Hódi K; Regdon G
    Eur J Pharm Sci; 2016 Dec; 95():62-71. PubMed ID: 27577010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin].
    Pan X; Julian T; Augsburger L
    Drug Dev Ind Pharm; 2008 Feb; 34(2):221-31. PubMed ID: 18302042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical approach to prepare solid dispersion drug product using spherical silicate.
    Nagane K; Kimura S; Ukai K; Ogawa N; Yamamoto H
    Int J Pharm; 2014 Nov; 475(1-2):364-71. PubMed ID: 25131150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.